SCHEMBL6804207

SCHEMBL6804207

C=CCCC(CC(C)C)C(=O)N(C(=O)OC(C)(C)C)[C@@H](Cc1ccccc1)C(=O)OC(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
REN P00797 4/20 0.36
MMP2 P08253 5/20 0.34
MMP3 P08254 5/20 0.34
MMP1 P03956 4/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
NPSR1 Q6W5P4 3/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34
ATM Q13315 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
PSEN1 P49768 2/20 0.34
PSEN2 P49810 2/20 0.34
APH1B Q8WW43 2/20 0.34
NCSTN Q92542 2/20 0.34
APH1A Q96BI3 2/20 0.34
PSENEN Q9NZ42 2/20 0.34
MMP7 P09237 1/20 0.33
ITGA4 P13612 1/20 0.33
ITGB7 P26010 1/20 0.33
BIRC2 Q13490 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6808419 0.92 NPSR1 (0.42) RENMMP2MMP3MMP1NPSR1
SCHEMBL6802521 0.91 REN (0.36) RENMMP2MMP3MMP1L3MBTL1
SCHEMBL6798658 0.89 ALOX5 (0.38) MMP2MMP3NPSR1MMP7BIRC2
SCHEMBL4425332 0.85 MMP2 (0.39) MMP2MMP3MMP1NPSR1MMP7
SCHEMBL4431902 0.85 MMP2 (0.39) MMP2MMP3MMP1NPSR1MMP7
SCHEMBL4423319 0.84 MMP2 (0.40) RENMMP2MMP3MMP1NPSR1
SCHEMBL6803242 0.80 NPSR1 (0.43) MMP2MMP3MMP1NPSR1MMP7
SCHEMBL6804726 0.79 HSD17B10 (0.39) MMP2MMP3MMP1L3MBTL1NPSR1
SCHEMBL4418750 0.78 MMP2 (0.38) MMP2MMP3MMP1NPSR1MMP7
SCHEMBL4428169 0.77 NPSR1 (0.43) MMP2MMP3MMP1NPSR1MMP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6790834-B1 Cytostatic agents BRITISH BIOTECH PHARMACEUTICALS, LTD. (GB) 2004-09-14 US disclosed
EP-1062202-B1 CYTOSTATIC AGENTS BRITISH BIOTECH PHARM (GB) 2003-01-15 EP disclosed
US-6462023-B1 SUCH AS 2-HYDROXY-HYDROXYCARBAMOYL-METHYL)-4-METHYL-PENTANOYLAMINE)-2-PHENYL -ETHANOIC ACID CYCLOPENTYL ESTER; INHIBITING HYPERPROLIFERATIVE TUMOURGENIC CELLS SUCH AS MELANOMA AND/OR LYMPHOMA CELLS BRITISH BIOTECH PHARMACEUTICALS, LTD. (GB) 2002-10-08 US disclosed
EP-0925278-B1 CYTOSTATIC HYDROXAMIC ACID DERIVATIVES BRITISH BIOTECH PHARM (GB) 2002-07-17 EP disclosed
US-6169075-B1 ANTITUMOR AGENT INHIBITING THE PROLIFERATION OF A RANGE OF RAPIDLY DIVIDING TUMOUR CELLS LIKE MELANOMA AND/OR LYMPHOMA CELLS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 2001-01-02 US disclosed
EP-1062202-A1 CYTOSTATIC AGENTS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 2000-12-27 EP disclosed
WO-1999046241-A1 CYTOSTATIC AGENTS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1999-09-16 WO disclosed
EP-0925278-A1 CYTOSTATIC HYDROXAMIC ACID DERIVATIVES BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1999-06-30 EP disclosed
WO-1998011063-A1 CYTOSTATIC HYDROXAMIC ACID DERIVATIVES BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1998-03-19 WO disclosed